Clinical Lab Product's May Podcast SeriesThursday, May 21, 2009, Part 2 of 3 Tumor Tissue of Origin Testing: Technology from Pathwork DiagnosticsSpecial guests: Dr. Federico Monzon, Medical Director of Molecular Diagnostics, at The Methodist Hospital in Houston and Dr. Shawn Becker, Pathwork Diagnostics' Vice President of Marketing and Reimbursement Discussion of last month’s Journal of Clinical Oncology validation study, in which close to 550 specimens were examined with a microarray gene expression technology from Pathwork. For additional information about Pathwork Diagnostic's tumor tissue of origin test, see www.pathworkdx.com.
|
 |
Experts here are available to answer all your questions!
ADDITIONAL ONLINE RESOURCES |
 |
|